Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age of onset in schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 2, 2010, Pages 610-618

  Vares, Maria ^a   Saetre, Peter ^a   Deng, Hong ^b   Cai, Guiqing ^c   Liu, Xiehe ^b   Hansen, Thomas ^d   Rasmussen, Henrik B ^d   Werge, Thomas ^d   Melle, Ingrid ^e,f   Djurovic, Srdjan ^e,f   Andreassen, Ole A ^e,f   Agartz, Ingrid ^a,e   Hall, Håkan ^a,g   Terenius, Lars ^a   Jönsson, Erik G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SICHUAN UNIVERSITY   (China)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Mental Health Services CPH   (Denmark)

^e UNIVERSITY OF OSLO   (Norway)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g UPPSALA UNIVERSITY   (Sweden)

Author keywords

Age of onset; Methylenetetrahydrofolate reductase gene (MTHFR); Schizophrenia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; WILD TYPE;

ADOLESCENT; ADULT; AGE OF ONSET; ALLELES; CASE-CONTROL STUDIES; CHINA; FAMILY HEALTH; FEMALE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCANDINAVIA; SCHIZOPHRENIA;

EID: 77349098572     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31030     Document Type: Article

References (66)

1. Adler Nevo G, Meged S, Sela BA, Hanoch-Levi A, Hershko R, Weizman A. 2006. Homocysteine levels in adolescent schizophrenia patients. Eur Neuropsychopharmacol 16:588-591.
2. Allen NC, Bagade S, McQueen MB, Ioannidis JPA, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. 2008. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet 40:827-834.
3. Angermeyer MC, Kuhn L. 1988. Gender differences in age at onset of schizophrenia. An overview. Eur Arch Psychiatry Neurol Sci 237: 351-364.
4. Applebaum J, Shimon H, Sela BA, Belmaker RH, Levine J. 2004. Homocysteine levels in newly admitted schizophrenic patients. J Psychiatr Res 38:413-416.
5. Arinami T, Yamada N, Yamakawa-Kobayashi K, Hamaguchi H, Toru M. 1997. Methylenetetrahydrofolate reductase variant and schizophrenia/ depression. Am J Med Genet 74:526-528.
6. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
7. Beratis S, Gabriel J, Hoidas S. 1994. Age at onset in subtypes of schizophrenic disorders. Schizophr Bull 20:287-296.
8. Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. 2000. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 69:228-232.
9. Cadieux B, Ching TT, VandenBerg SR, Costello JF. 2006. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res 66:8469-8476.
10. Cai G, Li T, Deng H, Zhao J, Hu X, Murray RM, Liu X, Sham PC, Collier DA. 2001. Affected sibling pair linkage analysis of qualitative and quantitative traits for schizophrenia on chromosome 22 in a Chinese population. Am J Med Genet 105:321-327.
11. Campbell IG, Baxter SW, Eccles DM, Choong DY. 2002. Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res 4:R14.
12. Cardno AG, Holmans PA, Rees MI, Jones LA, McCarthy GM, Hamshere ML, Williams NM, Norton N, Williams HJ, Fenton I, Murphy KC, Sanders RD, Gray MY, O'Donovan MC, McGuffin P, Owen MJ. 2001. A genomewide linkage study of age at onset in schizophrenia. Am J Med Genet 105:439-445.
13. Chango A, Boisson F, Barbe F, Quilliot D, Droesch S, Pfister M, Fillon-Emery N, Lambert D, Fremont S, Rosenblatt DS, Nicolas JP. 2000. The effect of 677C->T and 1298A->C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr 83:593-596.
14. Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, Chen MF, Pai A, John SW, Smith RS, Bottiglieri T, Bagley P, Selhub J, Rudnicki MA, James SJ, Rozen R. 2001. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 10:433-443.
15. Deng H, Liu X, Cai G, Sun X, Wang Y, Terwedow H, Wang Z, Xu X. 2002. A linkage disequilibrium study of methylenetetrahydrofolate reductase C677T and schizophrenia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19:198-200.
16. Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66:87-98.
17. Ellingrod VL, Miller del D, Taylor SF, Moline J, Holman T, Kerr J. 2008. Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants. Schizophr Res 98: 47-54.
18. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, Olivieri O, Jacques PF, Rosenberg IH, Corrocher R, Selhub J. 2002. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99:5606-5611.
19. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuve LP, Rozen R. 1995. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
20. Gangadhar BN, Panner Selvan C, Subbakrishna DK, Janakiramaiah N. 2002. Age-at-onset and schizophrenia: Reversed gender effect. Acta Psychiatr Scand 105:317-319.
21. Gilbody S, Lewis S, Lightfoot T. 2007. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: A HuGE review. Am J Epidemiol 165:1-13.
22. Gottesman II, Shields J, Hanson DR. 1982. Schizophrenia: The epigenetic puzzle. Cambridge: Cambridge University Press.
23. Gourion D, Goldberger C, Leroy S, Bourdel MC, Olíe JP, Krebs MO. 2005. Age at onset of schizophrenia: Interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport 16:1407-1410.
24. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R. 1994. Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification. Nat Genet 7:195-200.
25. Häfner H, Maurer K, Löffler W, Riecher-Rössler A. 1993. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 162:80-86.
26. Hänninen K, Katila H, Anttila S, Rontu R, Maaskola J, Hurme M, Lehtimäki T. 2007. Epidermal growth factor a61g polymorphism is associated with the age of onset of schizophrenia in male patients. J Psychiatr Res 41:8-14.
27. Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, Jonsson E, Andreassen OA, Djurovic S, Mjelle I, Agartz I, Hall H, Timm S, Wang AG, Werge T. 2007. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE 2:e873.
28. Jönsson EG, Larsson K, Vares M, Hansen T, Wang AG, Djurovic S, Rønningen KS, Andreassen OA, Agartz I, Werge T, Terenius L, Hall H. 2008. Two methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms, schizophrenia and bipolar disorder: An association study. Am J Med Genet Part B 147B:976-982.
29. Joober R, Benkelfat C, Lal S, Bloom D, Labelle A, Lalonde P, Turecki G, Rozen R, Rouleau GA. 2000. Association between the methylenetetrahydrofolate reductase 677C->T missense mutation and schizophrenia. Mol Psychiatry 5:323-326.
30. Kähler A, Djurovic S, Kulle B, Jönsson EG, Agartz I, Hall H, Opjordsmoen S, Jakobsen KD, Hansen T, Melle I, Steen VM, Werge T, Andreassen OA. 2008. Association analysis of schizophrenia on 18 candidate genes involved in neuronal migration: MDGA1 as a new susceptibility gene. Am J Med Genet Part B 147B:1089-1100.
31. Kempisty B, Mostowska A, Gorska I, Luczak M, Czerski P, Szczepankiewicz A, Hauser J, Jagodzinski PP. 2006. Association of 677C>T polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene with bipolar disorder and schizophrenia. Neurosci Lett 400:267-271.
32. Kempisty B, Bober A, Luczak M, Czerski P, Szczepankiewicz A, Hauser J, Jagodzinski PP. 2007. Distribution of 1298A>C polymorphism of methylenetetrahydrofolate reductase gene in patients with bipolar disorder and schizophrenia. Eur Psychiatry 22:39-43.
33. Kohn Y, Danilovich E, Filon D, Oppenheim A, Karni O, Kanyas K, Turetsky N, Korner M, Lerer B. 2004. Linkage disequlibrium in the DTNBP1 (dysbindin) gene region and on chromosome 1p36 among psychotic patients from a genetic isolate in Israel: Findings from identity by descent haplotype sharing analysis. Am J Med Genet Part B 128B:65-70.
34. Kraepelin E. 1919. Dementia praecox and paraphrenia. Huntington, NY: Krieger.
35. Kunugi H, Fukuda R, Hattori M, Kato T, Tatsumi M, Sakai T, Hirose T, Nanko S. 1998. C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol Psychiatry 3:435-437.
36. Levine J, Stahl Z, Sela BA, Gavendo S, Ruderman V, Belmaker RH. 2002. Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry 159:1790-1792.
37. Lewis SJ, Zammit S, Gunnell D, Smith GD. 2005. A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk. Am J Med Genet Part B 135B:2-4.
38. Lievers KJ, Boers GH, Verhoef P, den Heijer M, Kluijtmans LA, van der Put NM, Trijbels FJ, Blom HJ. 2001. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med 79:522-528.
39. Lima CS, Nascimento H, Bonadia LC, Teori MT, Coy CS, Goes JR, Costa FF, Bertuzzo CS. 2007. Polymorphisms in methylenetetrahydrofolate reductase gene (MTHFR) and the age of onset of sporadic colorectal adenocarcinoma. Int J Colorectal Dis 22:757-763.
40. Lin JJ, Yueh KC, Liu CS, Liu JT, Lin SZ. 2007. 5,10- methylenetetrahydrofolate reductase C677T gene polymorphism can influence age at onset of Parkinson's disease. Acta Neurol Taiwan 16:150-157.
41. Linnebank M, Montenarh M, Kolsch H, Linnebank A, Schnez K, Schweichel D, Pohl C, Urbach H, Heun R, Harbrecht U, Klockgether T, Wullner U. 2005. Common genetic variants of homocysteine metabolism in ischemic stroke: A case-control study. Eur J Neurol 12:614-618.
42. Mager A, Koren-Morag N, Shohat M, Harell D, Battler A. 2005. Family history, plasma homocysteine, and age at onset of symptoms of myocardial ischemia in patients with different methylenetetrahydrofolate reductase genotypes. Am J Cardiol 95:1420-1424.
43. Meltzer HY, Rabinowitz J, Lee MA, Cola PA, Ranjan R, Findling RL, Thompson PA. 1997. Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance. Am J Psychiatry 154:475-482.
44. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, Jia P, Assadzadeh A, Flanagan J, Schumacher A, Wang SC, Petronis A. 2008. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 82:696-711.
45. Muntjewerff JW, Hoogendoorn ML, Kahn RS, Sinke RJ, den Heijer M, Kluijtmans LA, Blom HJ. 2005. Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677TT genotype, and the risk for schizophrenia: A Dutch population based case-control study. Am J Med Genet Part B 135B:69-72.
46. Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M. 2006. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: A meta-analysis. Mol Psychiatry 11:143-149.
47. Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Ohta K, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aono M, Kameoka N, Sumitani S, Tomotake M, Kaneda Y, Taniguchi T, Ishimoto Y, Ohmori T. 2006. Brain -derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci Lett 401:1-5.
48. O'Connell JR, Weeks DE. 1998. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63:259-266.
49. Philibert R, Gunter T, Hollenbeck N, Adams WJ, Bohle P, Packer H, Sandhu H. 2006. Noassociation of the C677T methylenetetrahydrofolate reductase polymorphism with schizophrenia. Psychiatr Genet 16: 221-223.
50. Rasmussen HB, Timm S, Wang AG, Soeby K, Lublin H, Fenger M, Hemmingsen R, Werge T. 2006. Association between the CCR5 32-bp deletion allele and late onset of schizophrenia. Am J Psychiatry 163: 507-511.
51. Roffman JL, Weiss AP, Deckersbach T, Freudenreich O, Henderson DC, Purcell S, Wong DH, Halsted CH, Goff DC. 2007. Effects of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism on executive function in schizophrenia. Schizophr Res 92:181-188.
52. Roffman JL, Weiss AP, Purcell S, Caffalette CA, Freudenreich O, Henderson DC, Bottiglieri T, Wong DH, Halsted CH, Goff DC. 2008. Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia. Biol Psychiatry 63:42-48.
53. Salokangas RK, Honkonen T, Saarinen S. 2003. Women have later onset than men in schizophrenia-but only in its paranoid form. Results of the DSP project. Eur Psychiatry 18:274-281.
54. Sazci A, Ergul E, Guzelhan Y, Kaya G, Kara I. 2003. Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia. Brain Res Mol Brain Res 117:104-107.
55. Sazci A, Ergul E, Kucukali I, Kara I, Kaya G. 2005. Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: Association is significant in men but not in women. Prog Neuropsychopharmacol Biol Psychiatry 29:1113-1123.
56. Schurhoff F, Golmard JL, Szoke A, Bellivier F, Berthier A, Meary A, Rouillon F, Leboyer M. 2004. Admixture analysis of age at onset in schizophrenia. Schizophr Res 71:35-41.
57. Shi J, Gershon ES, Liu C. 2008. Genetic associations with schizophrenia: Meta-analyses of 12 candidate genes. Schizophr Res 104:96-107.
58. Tan EC, Chong SA, Lim LC, Chan AO, Teo YY, Tan CH, Mahendran R. 2004. Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. Psychiatr Genet 14:227-231.
59. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet 62:1044-1051.
60. Venkatesh BK, Thirthalli J, Naveen MN, Kishorekumar KV, Arunachala U, Venkatasubramanian G, Subbakrishna DK, Gangadhar BN. 2008. Sex difference in age of onset of schizophrenia: Findings from a communitybased study in India. World Psychiatry 7:173-176.
61. Vilella E, Virgos C, Murphy M, Martorell L, Valero J, Simo JM, Joven J, Fernandez-Ballart J, Labad A. 2005. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29:1169-1174.
62. Virgos C, Martorell L, Simo JM, Valero J, Figuera L, Joven J, Labad A, Vilella E. 1999. Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: Lack of association with schizophrenia. Neuroreport 10:2035-2038.
63. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. 1998. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169-172.
64. Wigginton JE, Abecasis GR. 2005. PEDSTATS: Descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 21:3445-3447.
65. Yu L, Li T, Robertson Z, Dean J, Gu N, Feng G, Yates P, Sinclair M, Crombie C, Collier DA, Walker N, He L, St Clair D. 2004. No association between polymorphisms of methylenetetrahydrofolate reductase gene and schizophrenia in both Chinese and Scottish populations. Mol Psychiatry 9:1063-1065.
66. Zintzaras E. 2006. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: A meta-analysis of genetic association studies. Psychiatr Genet 16:105-115.